Laurel Copeland to Angiotensin Receptor Antagonists
This is a "connection" page, showing publications Laurel Copeland has written about Angiotensin Receptor Antagonists.
Connection Strength
0.143
-
Mortensen EM, Nakashima B, Cornell J, Copeland LA, Pugh MJ, Anzueto A, Good C, Restrepo MI, Downs JR, Frei CR, Fine MJ. Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumonia-related outcomes. Clin Infect Dis. 2012 Dec; 55(11):1466-73.
Score: 0.095
-
Owen-Smith A, Stewart C, Green C, Ahmedani BK, Waitzfelder BE, Rossom R, Copeland LA, Simon GE. Adherence to common cardiovascular medications in patients with schizophrenia vs. patients without psychiatric illness. Gen Hosp Psychiatry. 2016 Jan-Feb; 38:9-14.
Score: 0.029
-
Mortensen EM, Copeland LA, Pugh MJ, Restrepo MI, de Molina RM, Nakashima B, Anzueto A. Impact of statins and ACE inhibitors on mortality after COPD exacerbations. Respir Res. 2009 Jun 03; 10:45.
Score: 0.019